InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (6 ops.)
Insider track record
CFODisclosed buys
0
Disclosed sells
6
T+90 hit rate
50%
T+90 mean return
-1.3%
Across 12 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Browse the detailed record of transactions filed by HOUGEN ELIZABETH L, Chief Financial Officer. Officer active across 1 company, notably Ionis Pharmaceuticals INC. Aggregated, 28 disclosures have been published. Split: 0 buy · 6 sells. Total volume traded: €98k. Activity tracked since 31 August 2021. The latest transaction was filed on 16 March 2026 (Levée d'options). Regulator: SEC (Form 4). All data is accessible without signup.
Declarations28 total
60,299 shares@ US$60.890.025% mcap49.9% of flowCommon StockSEC:0000874015-26-000146:0
60,299 shares@ US$60.890.025% mcap49.9% of flowCommon StockSEC:0000874015-26-000146
4,138 shares0Common StockSEC:0000874015-25-000077:0
23,887 shares0Common StockSEC:0000874015-25-000060:0
2,162 shares@ US$49.53991.2% of flowCommon StockSEC:0000874015-24-000199:0
4,140 shares0Common StockSEC:0000874015-24-000106:0
22,487 shares0Common StockSEC:0000874015-24-000075:0
45,225 shares@ US$47.3422.7% of flowCommon StockSEC:0000874015-24-000005:0
163 shares@ US$30.5150.1% of flowCommon StockSEC:0000874015-23-000113:0
4,140 shares0Common StockSEC:0000874015-23-000092:0
23,154 shares0Common StockSEC:0000874015-23-000065:0
202 shares@ US$28.9680.1% of flowCommon StockSEC:0000874015-22-000154:0
384 shares@ US$28.3730.0001% mcap0.2% of flowCommon StockSEC:0000874015-22-000088:0
22,050 shares0Common StockSEC:0000874015-22-000054
22,050 shares0Common StockSEC:0000874015-22-000054:0
166 shares@ US$33.7960.0000% mcap0.1% of flowCommon StockSEC:0000874015-21-000154:0
166 shares@ US$33.7960.1% of flowCommon StockSEC:0000874015-21-000154
541 sharesCommon StockSEC:0000874015-16-000107:0
216 sharesCommon StockSEC:0000874015-16-000107:1
312 sharesCommon StockSEC:0000874015-16-000107:2
125 sharesCommon StockSEC:0000874015-16-000107:3
654 sharesCommon StockSEC:0000874015-16-000107:4
261 sharesCommon StockSEC:0000874015-16-000107:5
1,875 sharesCommon StockSEC:0000874015-16-000107:6
747 sharesCommon StockSEC:0000874015-16-000107:7
25 of 28 declarations
About HOUGEN ELIZABETH L
Elizabeth L. Hougen is Chief Financial Officer at Ionis Pharmaceuticals Inc. She is responsible for the financial management of the company, including budgeting and financial analysis. With a strong background in corporate finance, Elizabeth plays a key role in financial strategy and decision-making. Her expertise is essential in ensuring the financial health of Ionis Pharmaceuticals Inc.
